Navigation Links
Patient Advocate Foundation Announces Additional Support for Co-Pay Relief Program Serving Multiple Myeloma Patients

Co-Pay Relief Program Provides Direct Financial Support for Pharmaceutical Co-Payments to Insured Patients in Medical and Financial Need

WASHINGTON, Nov. 12 /PRNewswire-USNewswire/ -- Patient Advocate Foundation (PAF) -- a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life threatening or debilitating diseases -- is pleased to announce that it has received additional funding support for serving patients with multiple myeloma through its Co-Pay Relief Program (CPR).

PAF's Co-Pay Relief Program provides direct financial support for pharmaceutical co-payments to insured patients, including Medicare Part D beneficiaries, who financially and medically qualify. Since the program's inception in April 2004, CPR distributed more than $50 million in assistance to over 25,000 patients who were unable to afford their pharmaceutical co-payments.

"Patient Advocate Foundation is committed to improving the quality of life of patients facing medical and financial hardship through our professional case management and Co-Pay Relief services. We are thrilled to announce additional funding for our Co-Pay Relief Program, which will allow us to offer financial assistance to a larger number of Multiple Myeloma patients across the nation," said Nancy Davenport-Ennis, Founder and CEO of PAF. "A cancer diagnosis can be the most overwhelming experience a person may ever face in his or her lifetime. Coupled with high-cost pharmaceutical co-pay expenses, the journey can become significantly more challenging to manage -- so we are particularly pleased to be able to offer assistance to more patients."

"We are so pleased that the Patient Advocate Foundation was able to secure this additional funding for Multiple Myeloma patients. Through PAF's Co-Pay Relief Program, this funding will help Multiple Myeloma patients to better utilize their healthcare coverage, which will lead to more thorough management of their disease," said Anne Quinn Young, MPH, Director of Programs, Multiple Myeloma Research Foundation.

Multiple myeloma is a cancer of the plasma cell, an important part of the immune system that produces antibodies to help fight infection and disease.

Patient Advocate Foundation and its companion organization, the National Patient Advocate Foundation (NPAF), were founded on the principle that health care is a basic human need and shared social responsibility. Annually, PAF receives thousands of contacts requesting information and assistance via their toll-free hotline as well as online, with complete direct, sustained case management services provided to patients from all fifty states free of charge. For more information about PAF, visit or call toll free (800) 532-5274. For more information about PAF's Co-Pay Relief Program visit or call toll free (866) 512-3861.

SOURCE Patient Advocate Foundation

SOURCE Patient Advocate Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Leukemia Drug May Help Some Ovarian Cancer Patients
2. Frost & Sullivan to Hold Analyst Briefing on the European Neurophysiological Monitoring Market, the Golden Standard in Patient Safety
3. Neurologists Receive New Patient Education Resources from Vivacare for Epilepsy Awareness Month
4. Local Neurosurgeon Co-Authors National Treatment Guidelines for Brain Tumor Patients
5. Drugs to treat anemia in cancer patients linked to thromboembolism
6. Men leave: Separation and divorce far more common when the wife is the patient
7. The Time is Now for Better Pain Care for Patients - Physician Leaders from Across Medicine Conclude from a Closed-Door Pain Summit
8. Some chest pain patients wait longer than 10 minutes to see ER physician
9. Doctors Spending More Time Now With Patients
10. Physician bias might keep life-saving transplants from black and Hispanic patients
11. Austin Cosmetic Dentist Offers $15,000 Worth of Dental Work in Most Interesting Patient in the World Video Contest
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... SAN FRANCISCO, Calif. ... that the organization has awarded Education and Developmental Therapies (EDT), an Applied Behavior ... award celebrates exceptional special needs providers that excel in synthesizing the areas of ...
(Date:12/1/2015)... ... 01, 2015 , ... Lutronic, a leading innovator of aesthetic and medical laser ... devices for sale in the United States. Clarity is a Superior Dual Wavelength ... lasers, into a single platform that is easy to own and operate. , ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... XTC ... selected 10 semi-finalists to head to Las Vegas for CES 2016, the world’s largest ... CEO of Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica Serra, ...
(Date:12/1/2015)... ... ... Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, has won a ... will be from the China Disabled Persons’ Federation, a central government association, for nearly ... children and adults suffering from severe and profound hearing loss . The company ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... Center Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani ... support Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015  The migration ... to develop shared care plans that help patients ... care plans will be digitally enabled, incorporate care ... needs and desires. They will also allow all ... patient,s health journey is optimal. That is the ...
(Date:12/1/2015)... , December 1, 2015 ... of eye and gaze tracking solutions, today announced that ... trackers as a component of its revolutionary new vision ... and medical and performance issues in patients. The new ... mass-market-ready eye tracking platform, which is ready to be ...
(Date:12/1/2015)... Dec. 1, 2015  Lexicon Pharmaceuticals, Inc. ... top-line data from its TELECAST Phase 3 ... treating carcinoid syndrome in cancer patients with ... benefit observed in its pivotal TELESTAR study.  ... companion to TELESTAR primarily to provide additional ...
Breaking Medicine Technology: